Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trialBernard Nordlinger, Thomas Gruenberger, Halfdan Sørbye et al.|The Lancet|2008Cited by 1.9k
Tumour response and secondary resectability of colorectal liver metastases following neoadjuvant chemotherapy with cetuximab: the CELIM randomised phase 2 trialGunnar Folprecht, Claus‐Henning Köhne, Jan Stoehlmacher et al.|The Lancet Oncology|2009Cited by 960
Bevacizumab, Capecitabine, and Oxaliplatin As Neoadjuvant Therapy for Patients With Potentially Curable Metastatic Colorectal CancerB. Gruenberger, Thomas Gruenberger|Journal of Clinical Oncology|2008Cited by 425
Molecular markers and biological targeted therapies in metastatic colorectal cancer: expert opinion and recommendations derived from the 11th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2009Eric Van Cutsem, Josep Tabernero, M. Dicato et al.|Annals of Oncology|2010Cited by 80